Medical News

RSS

Osteoarthritis directly linked to low-fat, high-carb food

Osteoarthritis is a degenerative joint disease and the most common cause of disability today. It was once considered a problem of the old but it is now commonly diagnosed in those as young as the mid-twenties and early thirties. According to the Arthritis Foundation, about four million, quality-adjusted life years are lost due to knee osteoarthritis alone.

20 May 2011

Analysis of 'Gang of Six' tensions: What will the impact be on deficit-reduction and entitlement reform plans?

News outlets examine what led to the exit of Sen. Tom Coburn, R-Okla., from this group of negotiators and what the new outlook is for the group to have a positive impact on congressional efforts to develop long-term deficit reduction strategies.

20 May 2011

RTOG reports on largest trial for newly diagnosed glioblastoma

RTOG reports on the largest trial to-date for patients with newly diagnosed glioblastoma demonstrating the importance and feasibility of prospective molecular analysis of tumor tissue although finding that patients received no additional benefit from dose-intensive temozolomide as compared to standard adjuvant temozolomide after combined temozolomide and radiotherapy.

20 May 2011

AMT presents long-term efficacy study of Glybera in treatment of lipoprotein lipase deficiency

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today results from a long-term efficacy study of Glybera (alipogene tiparvovec) that showed improved chylomicron metabolism could be used as a biomarker for increased lipoprotein lipase (LPL) activity in those patients missing the gene that produces this protein.

20 May 2011

New York Times examines DDT use in Uganda

"In the Apac region of Uganda, the United States focused on two conflicting agendas: developing organic farming and eradicating malaria, ultimately affecting the livelihoods of tens of thousands of farmers.

20 May 2011

Abbott appreciates FDA Advisory Committee recommendations to retain Trilipix indication for mixed dyslipidemia

The U.S. Food and Drug Administration today held an Endocrinologic and Metabolic Drugs Advisory Committee to review the results of the ACCORD Lipid study as they relate to the use of fenofibric acid (sold as Trilipix in the United States) in combination with a statin in patients with mixed dyslipidemia and at high risk of heart disease.

20 May 2011

Complementary and alternative health practices show promise for management of pain

A variety of complementary and alternative health practices —including meditation and relaxation techniques, manual therapies such as massage and spinal manipulation, meditative exercise forms such as yoga, Tai Chi, and ancient health practices such as acupuncture—show promise for contributing to the management of pain according to research presented at the Annual Scientific Meeting of the American Pain Society, www.ampainsoc.org.

20 May 2011

AIDS mortality in China drops by nearly two thirds since 2002 when country began free treatment program

China's HIV/AIDS-related mortality has dropped from 39.3 per 100 person-years in 2002 to 14.2 in 2009, or 64 percent, since the nation began providing free antiretroviral therapy (ART) in 2002, according to a study conducted by researchers from the Chinese Center for Disease Control and Prevention and published online Wednesday in Lancet Infectious Diseases, the New York Times reports (McNeil, 5/18).

20 May 2011

Bayer, Onyx to present Nexavar-chemotherapy combination Phase 2b trial data in breast cancer at ASCO 2011

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. today announced results from a Phase 2b trial evaluating Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic breast cancer previously treated with a bevacizumab-containing regimen, which showed that Nexavar was associated with statistically significant improvements in progression-free survival and time-to-progression.

20 May 2011

GIS discovery could help generate stem cells more efficiently for biomedical applications

A team of scientists from Genome Institute of Singapore (GIS) of the Agency for Science, Technology and Research (A*STAR) have shown how proteins involved in controlling genes work together to carry out their functions in stem cells and demonstrated for the very first time, how they can change interaction partners to make other types of cells.

20 May 2011

African LGBT advocates warn against cutting multilateral aid to Uganda

At a World Bank panel discussion in Washington, D.C., on homophobia in developing countries, LGBT advocates from Africa expressed concern that if multilateral development organizations cut aid to Uganda in protest of attempts to make homosexual acts crimes punishable by death, the human rights situation for them could worsen, the Washington Blade reports.

20 May 2011

Naltrexone improves clinical, inflammatory activity in Crohn's disease patients

Naltrexone reduced inflammation in Crohn's patients in a research study at Penn State College of Medicine.

20 May 2011

Free, online tool to track exercise-induced asthma

Running into breathing problems when you exercise? You may have exercise-induced bronchoconstriction (EIB), commonly referred to as exercise-induced asthma. The American College of Allergy, Asthma and Immunology (ACAAI) has developed a free, easy-to-use online tool to track your symptoms: MyEIBJournal.org.

20 May 2011

9/11 Health fund administrator chosen

The Justice Department on Wednesday chose a special master to administer a multibillion-dollar fund created to provide compensation to rescue workers and others sickened from exposure to toxic fumes, dust and smoke from ground zero after the 2001 terrorist attack.

20 May 2011

VBL to present positive VB-111 preclinical data in metastatic lung cancer at 14th ASGCT

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.

20 May 2011

Tornier announces launch of Porous Coated Affiniti Stem for shoulder joint replacement surgery

Tornier Inc. the operating subsidiary of Tornier N.V., a leading global medical device company focused on serving extremities specialists who treat orthopedic conditions of the shoulder, elbow, wrist, hand, ankle and foot, today announced the introduction of the Porous Coated Affiniti Stem for shoulder joint replacement surgery.

20 May 2011

Study: Costs get in way of cancer patients refilling their prescriptions

About 10 percent of cancer patients aren't taking the oral medicines they need either because of the cost or they feel they are already taking too many other drugs, according to a study released by health-care consulting company Avalere Health late Wednesday.

20 May 2011

HealthGrades identifies major flaws in hospital ratings study

The findings of a journal article published in the May issue of the Archives of Surgery are fundamentally flawed and could undermine patients ability to find high quality hospital care, according to HealthGrades. The article, Evaluating Popular Media and Internet-Based Hospital Quality Ratings for Cancer Surgery, compared outcomes for gastrointestinal cancer patients who underwent surgery at hospitals on HealthGrades' "America's 50 Best Hospitals" and US News and World Report's "America's Best Hospitals" lists.

20 May 2011

Lilly's cixutumumab Phase II study results in five subtypes of sarcoma to be presented at 47th ASCO

Eli Lilly and Company announced data from its Phase II study with cixutumumab in five subtypes of sarcoma, a cancer that develops from connective tissues in the body.

20 May 2011

Longer looks: Tough health care questions for GOP presidential contenders; Robotics help spike use of prostate treatment

For my money, the most interesting thing about Mitt Romney's health-care speech last week wasn't his struggle to defend Romneycare and distance it from Obamacare, but the largely hostile reception of the speech from the right.

20 May 2011

Medical News

Osteoarthritis directly linked to low-fat, high-carb food

Analysis of 'Gang of Six' tensions: What will the impact be on deficit-reduction and entitlement reform plans?

RTOG reports on largest trial for newly diagnosed glioblastoma

AMT presents long-term efficacy study of Glybera in treatment of lipoprotein lipase deficiency

New York Times examines DDT use in Uganda

Abbott appreciates FDA Advisory Committee recommendations to retain Trilipix indication for mixed dyslipidemia

Complementary and alternative health practices show promise for management of pain

AIDS mortality in China drops by nearly two thirds since 2002 when country began free treatment program

Bayer, Onyx to present Nexavar-chemotherapy combination Phase 2b trial data in breast cancer at ASCO 2011

GIS discovery could help generate stem cells more efficiently for biomedical applications

African LGBT advocates warn against cutting multilateral aid to Uganda

Naltrexone improves clinical, inflammatory activity in Crohn's disease patients

Free, online tool to track exercise-induced asthma

9/11 Health fund administrator chosen

VBL to present positive VB-111 preclinical data in metastatic lung cancer at 14th ASGCT

Tornier announces launch of Porous Coated Affiniti Stem for shoulder joint replacement surgery

Study: Costs get in way of cancer patients refilling their prescriptions

HealthGrades identifies major flaws in hospital ratings study

Lilly's cixutumumab Phase II study results in five subtypes of sarcoma to be presented at 47th ASCO

Longer looks: Tough health care questions for GOP presidential contenders; Robotics help spike use of prostate treatment

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News